GLP-1 drugs via WhatsApp pharmacy: what's actually legal and safe?

What did @farmaldezaharra actually say?

Straightforwardly: this video is not a health education post. It is a pharmacy soliciting orders for GLP-1 related products through a personal WhatsApp number, with shipping costs listed at 5.95 euros and free delivery above 60 euros. The creator says nothing medically substantive on camera. The transcript captured by automated tools is garbled and unrelated to the actual content, which the caption makes plain enough. This is a direct-to-consumer pharmaceutical sales pitch operating through a social media storefront.

The hashtags tell the real story: #GLP1, #ControlDelApetito (appetite control), #PérdidaDePeso (weight loss), and #Arkopharma, a French nutraceutical company that sells food supplements including some marketed for appetite management. The video has 158,200 views, which is a meaningful reach for what amounts to an unsolicited pharmaceutical advertisement.

Does the science back this up?

There is no scientific claim to evaluate here, which is itself the problem. Selling GLP-1 adjacent products without clinical framing, prescriber involvement, or safety context is not a neutral act. The evidence base for actual GLP-1 receptor agonists like semaglutide and tirzepatide is genuinely strong, but that strength does not extend to unregulated supplements marketed alongside those drug names.

The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed semaglutide 2.4mg produced 14.9% mean body weight reduction versus 2.4% with placebo over 68 weeks. That result is for a prescription-only injectable medication dispensed under medical supervision. Arkopharma's appetite supplements are not semaglutide. Placing them in the same hashtag ecosystem as #GLP1 implies a pharmacological equivalence that does not exist and has not been demonstrated in peer-reviewed literature.

What did they get wrong (or right)?

What they got wrong is the entire framing. Piggybacking on GLP-1 drug interest to sell over-the-counter or supplement products through an informal WhatsApp ordering system is misleading at minimum. It exploits a moment when patients are genuinely confused about what GLP-1 options are available, what is prescription-only, and what is a supplement. That confusion has real consequences.

If this pharmacy is legitimately licensed and is fulfilling actual prescriptions through a regulated dispensing pathway, the video gives no indication of that. There is no mention of a prescriber requirement, no safety screening, no contraindication disclosure. Selling weight loss products directly via WhatsApp to anonymous followers, without any clinical gatekeeping, is the kind of practice that Spanish regulatory body AEMPS and the European Medicines Agency have both flagged as a concern in the context of semaglutide shortages and counterfeit product proliferation (EMA, 2023 safety communication).

What they got right, if anything: the shipping price is transparent. That is a low bar.

What should you actually know?

If you are considering a GLP-1 medication for weight management, the path matters as much as the product. Semaglutide and tirzepatide are prescription drugs in Spain and across the EU. They require a licensed prescriber, a diagnosis or clinical indication, and ongoing monitoring. Ordering weight loss products through a pharmacy's WhatsApp account, prompted by a TikTok video, bypasses every one of those safeguards.

The supplement market has responded aggressively to GLP-1 interest by marketing products with loosely related ingredients, such as berberine, glucomannan, or chromium, as natural alternatives. None of these have clinical evidence matching GLP-1 receptor agonists. A 2023 review by Heymsfield et al. in Obesity Reviews found no over-the-counter supplement with effect sizes comparable to prescription GLP-1 agents. The #GLP1 hashtag on a supplement post is a marketing association, not a pharmacological claim, but patients deserve to know the difference.

If you see a pharmacy soliciting orders on social media for appetite or weight loss products tied to GLP-1 branding, ask directly: is this a licensed prescription dispensing service, or is it selling supplements under borrowed credibility? Those are very different things.